chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was administered Pfizer Covid 2nd dose vaccine and about 10 minutes later was stating she was light-headed, dizzy, feeling faint, and she wanted to throw up. Spoke to patient who was awake and called EMT to assist. EMT cleared with no findings. EMT stated normal blood sugar, blood pressure and that she was clear to leave. Patient waited in waiting area for approximately 1 hour until she felt better to leave.
iron deficiency; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received BNT162b2 (BNT162B2), in 2020 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IRON DEFICIENCY (non-serious) with onset 2020, outcome "unknown".  Additional information: Reporter states that her daughter got the booster dose of the Pfizer-BioNTech COVID-19 Vaccine and she's been dealing with an inability to process iron. My daughter has some kind of iron deficiency problem. Serious iron processing incapacity. I'd like to know where can I go within Pfizer, who would know of patients receiving the vaccine who end up with a serious iron processing incapacity. Now my daughter needs iron infusions every three weeks. This changes people's lives. This is too important. My daughter was too weak, it was hard for her to even try to stand up. "There have been 5 cases of this same thing happening in the withheld area. withheld Clinic has 6 physicians assigned to this particular issue. Iron processing deficiency. My daughter's internist said this was real. They made her an endoscopy, but the results aren't in yet. She was referred to hematology and they say her blood cells have an oval shape. I have to call everyday to the withheld Clinic to see if they have an opening. I happen to be buying a dress for my daughter's birthday an another person, someone on the queue, mentioned that they had the same problem two years ago after receiving the vaccine. Up to this day they still need frequent iron infusions. It exists and it's widespread. Two people who don't know each other, different ages, from different parts of the country. Caller would like to know if Pfizer is aware that certain people who receive the Pfizer-BioNTech COVID-19 Vaccine are coming down with an iron deficiency problem.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
103.1° rectal temp taken at 1930 (7:30 PM), fussiness, loss of appetite. Dressed her down, fluids, rest (will administer infant Tylenol if she wakes up later).
This spontaneous report as received from a registered nurse refers to a 4 month old patient. The patient's concurrent conditions, medical history and drug allergies were not reported. On 30-NOV-2016, the patient was vaccinated with improperly stored ROTATEQ, oral, (dose not reported) from lot # M031802 with expiry date: 09-NOV-2017 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all correspondence has been received. Sender's Comments: US-009507513-1610USA008140: US-009507513-1610USA014705.
By 6:00pm my left arm was extremely sore, to the point that I could not move it. By 10pm, I had chills and significant fatigue. Around 2am, I developed a fever of 101F, weakness, dizziness, and nausea. At 6:30am I still had a fever of 101F, dizziness, and nausea. By 8am I developed a severe headache, fever of 100F, and remained dizzy. Finally at 12pm, my fever is back up to 101F, with severe headache, all-over muscle weakness, and fatigue.
Patient received her Moderna booster of 0.5mL instead of 0.25mL. Patient has not experienced any adverse reaction. Reporting due to error in dose.
Felt a bit ill the day of the shot. Tried to help  do dinner later that day and turned white and sweaty and had to sit down for about 15 minutes. The next day injection site began to swell. By the 8th day post injection it was hard to the touch, about the size of a large marshmallow and hard to the touch. No skin discoloration,  but felt warm to touch and very itchy. Used Lanacanevto stop the itch.  Today the 11th, most of swelling is gone and just a little tender to touch. Did not contact anyone medical about this, but a friend said i should report it.
Received vaccine on 02/02,  4 weeks pregnant on 02/03 02/03-02/05: Severe lethargy, tiredness, pain at injection sites, fever all lasting  48 hours. Symptoms subsided after taking tylenol on 02/05.  I'm not attributing this to the vaccine, but on 02/12, my hcg started to plateau and decline, no egg yolk or fetal pole was seen at 6 weeks (2/17). Sac was measuring at 5 weeks. I eventually had a miscarriage on 2/21
April 17-18, 2004 Temp of 100.4-vomited several times.  4/20/04 Noted red spots- welt-like spot- on trunk of body-no drainage from welts-no temp, no N/V. Does not itch- several welt on upper part of legs.
Information has been received from a consumer regarding a case in litigation concerning herself (a female patient of unknown age) with no drug allergies and herpes viral infection in her eye and glaucoma who on unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). Concomitant therapy included acyclovir, dorzolamide hydrochloride (+) timolol maleate and prednisolone. It was reported that "for about 6 year the patient had a herpes viral infection in her left eye which she was getting treated for, but then she received ZOSTAVAX (Merck) and about 6 to 8 weeks later she lost total vision in her left eye. The consumer reported that she saw the eye doctor who did a vision test and was told she has no vision in her left eye." The patient had not recovered. Upon internal review, lost total vision was determined to be an other important medical event. No further information is available.
So, I had a chronic cough. I was lethargic and I had a headache, body aches. I went to get COVID test, and all were negative. I was prescribed Albuterol on 11/29/2021. Then went back to the doctor on 12/3/2021. I also went to the doctor on 12/24/2021 because I was still having complications and coughing.
Pt became pregnant while suing ORTO - TRICYCLEN LO, which she failed to take regularly. LMP 1/27/09 - Had received GARDASIL 12/11/08 - 2/20/09.
This spontaneous report was received from an unspecified reporter referring to a female patient of unknown age who on 15-MAY-2014, was vaccinated with a dose of M-M-R II, (HAS, lot# reported as J009885, expiration date 12-FEB-2015), in the left deltoid. These are their out of range temp logs and the vaccines that had been administered to the patient. Additional information has been requested.
The next morning by 7am, 2/15, had severe intense vertigo and fell to her knees. EMS took her to  Medical Center. Work-up for cardiac and neurological clear; everything came was negative including MRI. PCP saw patient at ER and she still had vertigo and couldn't lift head from the pillow. Patient was not admitted to hospital but discharged to assisted living facility. PCP visited patient at facility yesterday. After discharge, patient developed a localized site reaction at injection site--8cm in diameter, warm, swollen to touch. Patient given Meclizine for vertigo and dizziness but it was not helpful at all. In the nursing home received some vestibular physical therapy but still cannot ambulate because of vertigo. Patient still is at facility and will stay there until vertigo resolves. PCP will follow-up with patient after discharge. There were no comments from the patient about adverse events after the first dose of the vaccine.
Red circular area near vaccination site, swolledn and feels hot. No treatment at this time. Started 9 days after vaccination. No outcome yet
Hx latex allergy; received MENACTRA 7-29-08.  Mom questioning reaction to MENACTRA due to latex in stopper.  Child had fever, sore throat, ?difficulty swallowing.  Spoke with medical person at Sanofi who advised pt. be seen.
Rash on arm that got vaccine.  A bit itchy.  Area around injection site is slightly raised relative to the injection site, which slightly indents.  Also, I still have a bruise from the shot.
Within 4 hours of receiving vaccine:  Body aches Low back pain Fever Headache Dizziness Numbness/tingling in all fingertips Chills
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 73-year-old female patient who received SHINGRIX for prophylaxis. On 27th March 2019, the patient received the 1st dose of SHINGRIX (intramuscular). In March 2019, less than a week after receiving SHINGRIX, the patient experienced injection site swelling, injection site erythema and injection site pain. The patient was treated with ADVIL. On an unknown date, the outcome of the injection site swelling, injection site erythema and injection site pain were unknown. It was unknown if the reporter considered the injection site swelling, injection site erythema and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX intramuscularly and experienced swelling and redness and pain around the injection site about 3 inches in diameter. The reporter was aware of injection site pain from patient.
Around 11am or noon of the same day the vaccine was given, patient states he began feeling nauseated, right arm felt "hot" and sore to touch.  Then he started aching in legs and arms, chills, felt as if he had a fever. Felt bad the next day and did not go to work (11-12-14)  Went to work the next day, right arm started swelling with redness...now has redness from shoulder to elbow and is sore, has had some hot flashes.
Husband presented to Vaccine clinic on 3/5 with the following report: "Wife has had chronic debilitation from MS for many years. Unable to ambulate without support well, unsteady gait. Unable to cook d/t inability to feel hands, sharp objects, hot temps are a danger. Approx 3-4 hours after 1st dose Moderna, wife was up without her walker, vacuuming and cooking. She hasn't had this level of mobility in many years."  Connected husband to in-house pharmacist, but we could not correlate why this has occurred. Husband is convinced it has something to do with the vaccine.
OFF & ON RASH AT SITE OF INJECTION, REPORTED TO PHARMACY ON 2/22/2014.
It was four days, it felt like a truck hit me. I had chills, and body aches. Two weeks ago, I did test positive for COVID-19. I had a fever of 101.8. I had chest congestion, I was very fatigued, and I was coughing. I coughed so much that I tore a muscle in my chest. I was Short of breath. I had body aches, and headaches. These symptoms lasted for 18 days. I lost my sense of taste, and smell which have not come back yet.
Immobile morning of 12/11/16, went to ER. Dr. diagnosed problem as Guillain-Barre syndrome. Diagnosed near death, given 5 days 24/7 of IGG infusion-felt weak within a few days, tried resting, weakness continued.
lit ref;pt recv vax & devel marked fatigue, n, fever, diarrhea, oliguria & ecchymosis in lower extremities;dx thrombotic thrombocytopenic purpura (TTP);acute renal failure, microangiopathic hemolytic anemia,neuropsychiatric signs
High Fever 102-103F, headaches, body and muscle aches, high heart rate, cough. Went to physician. Bed rest and ibuprofen.
Left upper arm redness and swelling. Treatment cool compresses, ZYRTEC or BENADRYL OTC hydrocortisone cream.
Dizziness lightheadedness; feeling of warmth. Narrative:  Blood pressure 128/82; pulse 84  Other Relevant History:
Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
The vial was drawn as a full dose (0.5mL) instead of a booster dose (0.25mL) . The patient received the vaccine. He had normal symptoms afterwards, symptoms resolved within 48 hours.
Face hot tingly, headache for 2 days, dizzy light head, chills body aches hot one minute then cold just sick vomiting
Dear Dr.,  Thank you for your interest in my unusual case.   Yes, my Vitiligo continues to spread rapidly.   My immune system is attacking my skin pigment rapidly.   I can see changes almost on a daily basis.  I am convinced the second Moderna shot is causing this sudden (unexpected) immune response after 30+ years of stable and small Vitiligo patches.   All my opinion .    Just a coincidence?    I don't think so.      I have to be very careful with the sun.    I have already burned the backs of both hands.    I use lots of sunscreen outdoors.    I am hopeful for a good outcome over time.     Sorry, no before and after photographs.    Blessings!  :)  This is interesting. I am going to ask around and see if any of my colleagues have seen this. Has the vitiligo continued to progress at this point??  Thank you for the prompt reply. As I stated below, Dr. has already diagnosed my vitiligo at a previous visit. The purpose of my below message was "FYI" to let the Dr. know that my vitiligo has suddenly, rapidly progressed after I had two Moderna Covid vaccines. My immune system has reacted somehow. That may be just a coincidence. I predict that at the current rapid rate of spread, my vitiligo will completely disappear and be gone and my skin will look normal again by the end of the year. If correct, that is good news. Does that mean, in my case, the two Covid vaccine shots were a cure for my vitiligo? Something for Dr. to think about. I do not need an appointment.  In order for the Dr. to treat or diagnose he would need to see you in the office.   I am a past Dr. patient. I am a 75 years old male. My 30+ year old vitiligo condition was very stable and very small patches. I got the two covid Moderna vaccines Feb 1st, and March 1st, 2021. Since then, my vitiligo has rapidly spread everywhere. Maybe just a coincidence, maybe not????
redness at injection site; swelling in left arm; fever in left arm; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 78-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 20Mar2021 13:30 (Lot number: EP7534) at the age of 78 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162B2 (Dose 1, Single, Administration Site: left arm, Lot No.: EN6200), administration date: 01Mar2021, when the patient was 78 years old, for Covid-19 immunization, reaction(s): "No adverse event". The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 23Mar2021, outcome "recovering", described as "redness at injection site"; VACCINATION SITE SWELLING (non-serious) with onset 23Mar2021, outcome "recovering", described as "swelling in left arm"; PYREXIA (non-serious) with onset 23Mar2021, outcome "recovering", described as "fever in left arm". Additional Information: The patient has not taken any other products and has no history. The patient received both doses of the COVID-19 Vaccine. She read the information in the pamphlet that they gave her. She has not been to her physician. She received the second dose of the vaccine on 20Mar2021, given in her left arm. Since getting the second dose, she had redness, swelling and fever in her left arm. She received the first dose on 01Mar2021. It was administered in her left arm. Lot: EN6200. She was worried because she didn't know since both were given in the left if that is why she experienced this. The patient has no history of all previous immunization with the COVID-19 Vaccine and has no additional vaccines administered on same date of the COVID-19 Vaccine. The adverse events did not require emergency room nor physician office visit. The patient has no medical history (including any illness at time of vaccination), has no family medical history relevant to adverse events and no relevant tests done.  No follow-up attempts are possible. No further information is expected.
Severe head, neck, back pain. Cognitive decline. Brain fog. Fever, blacking out (syncope). Pressure in head and neck, dizziness. Nausea. Chronic fatigue/several weeks duration/have seen Neurologist, ENT, Rheumatologist/many labs, MRI, CAT scan, LP - no definitive diagnosis to date.
This spontaneous case, initially received on 01-Jun-2017, was reported by other health professional (registered nurse) and concerns students in an academic campus, who received flu vaccine. This case deals with 18th of 23 reports. From 03-Oct-2016 to 04-Oct-2016, 176 students were vaccinated with FLUCELVAX in the total of 258 students in the campus. In the spring of 2017, an outbreak of the flu occurred and lasted for approximately 10 days. The reporter stated that, from 13-Apr-2017 to 18-Apr-2017, they treated 22 students with flu and among them 5 students had the vaccine on campus. In the beginning of 18-Apr-2017, they treated another 23 students with flu symptoms and only 3 of those had not received the flu vaccine. The students were tested positive for influenza A via rapid flu test with nasopharyngeal swab. This case concerns a 16-years-old adolescent patient of unspecified gender. On 03-Oct-2016, the patient received FLUCELVAX QIV (dose, route of administration and anatomical location: not reported, batch number: 185888, expiration date: 31-May-2017). On 24-Apr-2017, the patient was tested positive for influenza A via rapid flu test with nasopharyngeal swab (characterized as vaccination failure). Based on the investigation performed, it can be concluded that FLUCELVAX 185888 was manufactured in compliance with the approved internal procedures and in accordance with the quality requirements. No evidence was found that the LOE complaint was the result of the Fill Finish or Bulk manufacturing process and no trends were identified for the batch number 185888, or any other FLUCELVAX QIV batches from the 2016-2017 FLUCELVAX Commercial season. Therefore no internal root cause could be confirmed. Outcome of influenza A virus infection and vaccination failure was not reported. The reporter did not assess the seriousness and did not provide the causality between events and suspect vaccine. The reporter stated that, the students received flu vaccine had less severe symptoms than those who had not received the flu vaccine. Batch review report (QAIR number 1022277) received from quality assurance department on 29-Jul-2017: QA investigation results were updated. Narrative amended accordingly. Non-significant case correction received on 10-Aug-2017: The narrative was corrected.
This case was reported by a lawyer and described the occurrence of joint pain in a male subject of unspecified age who was vaccinated with LYMERIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject's medical history, concurrent conditions and concurrent medications were not reported. On an unspecified date the subject received unspecified dose of LYMERIX (unknown). An unknown amount of time after vaccination with LYMERIX, the subject experienced joint pain, flu-like symptoms, fatigue, autoimmune disease, activities of daily living impaired, memory loss, headache, joint inflammation, stiffness, numbness, rheumatological symptoms, neurological impairment and cognitive impairment. At the time of reporting the outcome of the events was unspecified. This information was received via a Statement of Injuries. Follow up information was received on 05 January 2009 via medical records. The subject's medical history included recurrent synovitis and symptoms consistent with gouty arthropathy/arthritis. The subject received his first and second doses of LYMERIX on 16 March 1999 and 27 April 1999. A progress note dated 20 April 1999 indicated that the subject had had "no recurrent attacks of acute arthropathy." On 23 February 2000, the subject received his third LYMERIX, and also reported a three week history of fatigue. Between 05 February 2001 and May 2001, the subject presented with complaints of neck stiffness and headaches. On 26 January 2002 and 02 May 2002, the subject was evaluated by an orthopedist for elbow swelling, and was diagnosed with chronic left elbow bursitis.
The day after I had the injection I noticed heavy heart palpitations/skipped beats.  I ignored it, chalking it up to stress.  I ignored it for 6 weeks even though it got worse daily.  Then on 4/19/21 I ended up in the emergency room, thought I was having a heart attack.  After 12 hours and many tests the cardiologist told me he believes it is Supraventricular tachycardia.  I was given a beta blocker and that is helping but it has not gone away.  The cardiologist is still working on figuring out the problem.
Information has been received from a nurse practitioner (NP) concerning an adult female with three children, who underwent varicella titers prior to getting pregnant. The patient titers "kept coming back negative," therefore the patient received two doses of Varivax prior to each pregnancy (total of 6 doses "over many years"). Unspecified medical attention was sought. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
This spontaneous report was received from a registered nurse and refers to an 11 month old male patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 29-OCT-2018 the patient was vaccinated with VAQTA, VARIVAX and M-M-R II (inappropriate schedule of vaccine administered). All three vaccines were indicated for prophylaxis (dose, frequency, route of administration, lot number and expiration date were not reported). No adverse effect was reported.
Approximately 3 hours after administration awoke with shrill, high pitched shreiking cry with back arching. Did not recognize any attempts to console including acknowledgement of attempted nursing. Continued for an hour without interruption until fell asleep. Would begin screams if moved. Slept remainder of day. One entire thigh was noted to be swollen.
pt recv vax & exp malaise, h/a & sleeping cont since 6PM on 4FEB98;denies redness, swelling @ the site or elevated temp;pt exp some pain deep in muscle;the following day @ noon pt cont to exp malaise, h/a & sleeping cont;taking APAP